Cytodyn Inc (CYDY)

[C-20]

Was reading the FDA approval process which stated once the CDER reviewers look at the condition or illness a drug is intended for ,then evaluate the treatment landscape which gives the context for weighing a drugs risk and benefits. A drug intended to treat patience with a life threatening disease for which there is no other treatment that drug may have benefits that outweigh risks even if those risks would be considered unacceptable. Leronlimab provides benefits that far outweigh any potential risks because there are no real risks. This explains why remdesivir was approved at one time but doesn’t explain why Leronlimab still hasn’t been approved not to mention those requirements are during normal times these are anything but normal times. There is no way this drug doesn’t get approved after our data is reviewed unless I missed something nothing else has been approved for S2C covid 19